AbbVie's Venclexta Receives Accelerated Approval From FDA, Stock Ticks Higher
April 12, 2016 at 08:49 AM EDT
Shares of AbbVie Inc (NYSE: ABBV) were trading higher by nearly 2 percent early Tuesday morning after the company announced that the ...